ChemoMouthpiece, LLC

06/24/2026

We're looking forward to Dr. Vikas Dembla's presentation at MASCC/ISOO 2026 in Melbourne, Australia.

Dr. Dembla will share insights on the use of intraoral device-based cryotherapy in patients being treated with Antibody-Drug Conjugates (ADCs) who experience oral mucositis.

Presentation: "Device-Based Cryotherapy as an Effective Intervention in Mitigating Oral Mucositis in Patients Being Treated with Antibody-Drug Conjugates (ADCs)"

📅 June 26, 2026
🕓 16:15–16:25
📍 Room 204

View full details: https://mascc.org/annualmeeting2026/program/

Stop by Booth #15 to learn more about the Chemo Mouthpiece® medical device, an FDA 510(k)-cleared oral cryotherapy device intended to cool the oral mucosa to reduce the incidence and severity of chemotherapy induced oral mucositis in adult patients.

Learn more and see Important Safety Information: chemomouthpiece.com/resources

06/23/2026

The Chemo Mouthpiece team is headed to this week in Melbourne, Australia.

We're excited to join oncology and supportive care professionals from around the world to discuss advances in cancer supportive care and the Chemo Mouthpiece® oral cooling device.

If you're attending, stop by Booth #15 to meet our team. We hope to see you there!

📍 Melbourne, Australia
📅 June 25–27, 2026


Multinational Association of Supportive Care in Cancer - MASCC ISOO - International Society of Oral Oncology

06/18/2026

📢 We're excited to share today's press release announcing our partnership with Zeal Specialty Pharmacy to support patient access to the Chemo Mouthpiece® oral cooling device.

Oral mucositis (often called chemo mouth sores) is one of the most common and debilitating side effects of chemotherapy and may impact a patient's ability to eat, speak, maintain nutrition, and continue treatment.

Together with the Zeal team, we remain focused on what matters most: supporting patients facing oral mucositis during chemotherapy treatment.

Read the full announcement https://finance.yahoo.com/healthcare/articles/chemomouthpiece-llc-announces-partnership-zeal-154400922.html

Chemomouthpiece, LLC, a privately held medical device company focused on supportive oncology care, today announced a new partnership with Zeal Specialty Pharmacy to support patient access to the Chemo Mouthpiece® oral cooling device.

06/16/2026

Mouth sores (also called oral mucositis) are one of the most painful side effects of chemotherapy, causing pain, discomfort and difficulty eating, drinking, or speaking.

The Chemo Mouthpiece® is an FDA cleared oral cooling device designed by a cancer survivor to help reduce the incidence and severity of chemotherapy induced oral mucositis.
- Use before, during, and after chemo infusions
- Non-medication
- Cools the entire oral cavity evenly

By cooling the mouth, the device promotes vasoconstriction (narrowing of the blood vessels) which reduces blood flow, limiting chemotherapy circulation to oral tissues and reducing damage.

It’s simple and easy-to-use and clinically proven.* Ask your healthcare provider about the Chemo Mouthpiece as part of your supportive care plan.

Learn more and see Important Safety Information at ChemoMouthpiece.com
*Data on file

06/11/2026

June is National Cancer Survivors Month. According to the National Cancer Institute, there are an estimated 18.6 million cancer survivors in the United States as of May 2025, representing approximately 5.4% of the population.

June is an opportunity to recognize these survivors as well as the caregivers, researchers, clinicians, and communities who support them every step of the way. Managing treatment-related side effects and maintaining quality of life remain important considerations throughout the cancer journey.

Visit https://cancercontrol.cancer.gov/ocs/about/survivorship-month to learn more and to get involved.

06/10/2026

Some of the hardest parts of chemotherapy aren't always the ones people talk about.

Some chemotherapy side effects appear early in treatment.

Mouth sores (oral mucositis) may start with redness, tenderness, or sensitivity in the mouth before progressing to painful sores.

Because symptoms can worsen quickly once treatment begins, understanding the risk of mouth sores before treatment begins can help patients report changes early and have discussions with their healthcare team about supportive care options, including oral cryotherapy.

06/04/2026

Exciting oncology advances were highlighted at the American Society of Clinical Oncology (ASCO) meeting last weekend, bringing new hope to patients and families facing cancer.

As treatment options continue to evolve, the importance of educating patients about potential side effects before treatment begins remains a vital step.

Oral mucositis (often referred to as mouth sores) is a common and debilitating side effect of many chemotherapy treatments. In some patients, oral mucositis can slow or delay cancer treatment.

Early awareness, supportive care planning, and patient education can help patients better prepare for their treatment journey. Innovations in cancer treatment and patient support should advance together.

06/02/2026

Promising new research highlighted at the American Society of Clinical Oncology ( ) conference this weekend offers new hope for patients and families affected by pancreatic cancer.

As cancer treatments continue to evolve, it is vital to ensure patients are educated about potential treatment-related side effects and supportive care options before therapy begins.

Patient education, symptom awareness, and proactive supportive care planning remain essential components of comprehensive cancer care.

Explore how daraxonrasib is transforming pancreatic cancer treatment by doubling survival rates, as showcased at ASCO 2026.

05/27/2026

When preparing for chemotherapy, most patients expect side effects like nausea, fatigue, or hair loss. But some side effects affect the mouth.

Chemotherapy can cause mouth sores (oral mucositis) that make eating, drinking, and even speaking uncomfortable during treatment.

Learning about mouth sores BEFORE chemotherapy begins allows patients to know the symptoms and talk with their care team about proactive options such as oral cryotherapy.

Learn more and see Important Safety Information at chemomouthpiece.com

05/21/2026

Thank you to everyone who stopped by our booth at to learn more about the Chemo Mouthpiece® oral cooling device.

Our team is grateful to connect with so many oncology nurses passionate about helping patients manage the painful effects of oral mucositis during chemotherapy treatment.

Please don’t hesitate to reach out if we can help support you or your patients in any way.

Learn more: chemomouthpiece.com
How to prescribe:https://chemomouthpiece.com/wp-content/uploads/Chemo-Mouthpiece-Referral-Form.pdf